Halobetasol propionate - CAS 66852-54-8
Catalog number:
66852-54-8
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C25H31ClF2O5
Molecular Weight:
484.96
COA:
Inquire
Targets:
Others
Description:
Halobetasol propionate act by the induction of phospholipase A2 inhibitory proteins.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Vitamin B1
MSDS:
Inquire
1.Impurity profiling and a stability-indicating UPLC method development and validation for the estimation of related impurities of halobetasol propionate in Prakash L1, Malipeddi H2, Subbaiah BV3, Lakka NS3. J Chromatogr Sci. 2015 Jan;53(1):112-21. doi: 10.1093/chromsci/bmu027. Epub 2014 May 2.
A simple, short and stability-indicating reverse phase-ultra-performance liquid chromatography method was developed and validated for the quantitative determination of related impurities of halobetasol propionate in halobetasol propionate 0.05% cream formulation. The proposed method was developed on an ACQUITY UPLC™ BEH Phenyl (2.1 × 100 mm, 1.7 µm) column at 40°C with a mobile phase containing a gradient mixture of potassium hydrogen phosphate buffer and acetonitrile and methanol as modifiers with a runtime of 13.0 min at a monitored wavelength of 242 nm. A simple preparative method and liquid chromatography-mass spectrometry-compatible UPLC method also were developed for the isolation and identification of impurities and degradation products. The drug was subjected to forced-degradation conditions and found to degrade significantly. The stability-indicating capability of the developed method is established by analyzing forced-degradation samples in which the spectral purity of halobetasol propionate is ascertained along with the separation of degradation products from the analyte peak.
2.A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Ammonium Lactate Lotion 12% and Halobetasol Propionate Ointment 0.05% in the Treatment and Maintenance of
Emer JJ1, Frankel A, Sohn A, Lebwohl M. J Clin Aesthet Dermatol. 2011 Feb;4(2):28-39.
Consensus recommends a gradual reduction in the frequency or steroid potency of topical corticosteroids following clinical improvement in the treatment of psoriasis, although no established guidelines have been developed. The authors sought to evaluate a combination regimen in the treatment and maintenance of psoriasis. Patients with mild-to-moderate psoriasis were enrolled (n=55) in a randomized, double-blind, placebo-controlled study using ammonium lactate lotion and halobetasol ointment. Those with initial improvement of target plaques after two weeks of combination treatment twice daily were randomized to a maintenance phase (n=41). Patients applied ammonium lactate lotion twice daily everyday and either placebo ointment (n=20) or steroid ointment (n=21) twice daily on weekends only. Forty-one of 55 patients (74.6%) were rated as "clear" (0) or "almost clear" (1) after two weeks of combination treatment. In the maintenance phase, the probability of physician global assessment worsening at six weeks in the steroid group was only 10 percent while in the placebo group the probability rose to 75 percent (p<0.
3.The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.
Lee CS1, Koo J. J Drugs Dermatol. 2009 Aug;8(8):751-5.
BACKGROUND: This study compared the efficacy of a novel, topical class I synthetic, 0.10% fluocinonide corticosteroid with two other class I corticosteroids and placebo for the treatment of plaque psoriasis.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 8067-24-1 Codergocrine mesilate

Codergocrine mesilate
(CAS: 8067-24-1)

Codergocrine mesilate is a mixture of the methanesulfonate salts of three dihydrogenated ergot alkaloids. It binds with high affinity to the GABAA receptor Cl- ...

AT-584
(CAS: 16810-17-6)

AT-584, an azoniatricyclo compound, could have potential biological activity in pharmaceutical studies.

CAS 99-15-0 Ac-DL-Leu-OH

Ac-DL-Leu-OH
(CAS: 99-15-0)

Acetylleucine is a drug mianly used to treat the vertigo.It has been listed.

LY-113174
(CAS: 112959-07-6)

LY-113174 is a novel class of nonsteroidal aromatase inhibitor. It may prove useful in the treatment of estrogen-dependent diseases.

CAS 81907-62-2 Ganoderic acid A

Ganoderic acid A
(CAS: 81907-62-2)

Ganoderic acids are a class of related triterpenoids found in Ganoderma mushrooms. Now ganoderic acid A and ganoderic acid B are well characterized. Some ganode...

CAS 202914-84-9 Lomitapide Mesylate

Lomitapide Mesylate
(CAS: 202914-84-9)

Lomitapide Mesylate is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.

CAS 89-25-8 Edaravone

Edaravone
(CAS: 89-25-8)

Edaravone is a novel potent free radical scavenger that reduces reactive oxygen species, inhibites apoptosis, and blocks nonenzymatic peroxidation and lipoxygen...

CAS 820957-38-8 Retosiban

Retosiban
(CAS: 820957-38-8)

Retosiban is a oxytocin receptor antagonist. It was developed by GlaxoSmithKline for the treatment of preterm labour. Retosiban has high affinity for the oxytoc...

C-DIM12
(CAS: 178946-89-9)

C-DIM12 is a novel synthetic activator of Nurr1. C-DIM12 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro. .

AM-206
(CAS: 1219935-54-2)

AM-206 is a bio-active chemical but no detailed data has been published yet.

CAS 1007-33-6 Propylhexedrine Hydrochloride

Propylhexedrine Hydrochloride
(CAS: 1007-33-6)

Propylhexedrine Hydrochloride is an α-adrenergic sympathomimetic amine. It acts as a local vasoconstrictor. It is a stimulant drug that is used medicinally as a...

CAS 124190-19-8 FR 901235

FR 901235
(CAS: 124190-19-8)

This active molecular is an immunoactive substance that produced by Paecilomyces carneus F-4882, an imperfect fungus. FR-901235 can lead to the mitogen-induced ...

CAS 1135237-88-5 Exherin trifluoroacetate

Exherin trifluoroacetate
(CAS: 1135237-88-5)

Exherin trifluoroacetate is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities, which selectively...

CAS 112111-44-1 (S)-(+)-Modafinic acid

(S)-(+)-Modafinic acid
(CAS: 112111-44-1)

(S)-(+)-Modafinic acid is the major metabolite of Modafinil(HY-10521A), which is a central nervous system vigilance promoting agent, which posseses neuroprotect...

Avarofloxacin hydrochloride
(CAS: 1001162-01-1)

Avarofloxacin hydrochloride is an antibacterial drug agent.

Vadadustat
(CAS: 1000025-07-9)

Vadadustat is a potent Hypoxia-inducible factor-proline dioxygenase inhibitor, which leads to stabilization and increased levels of HIFα. It is used for the tre...

CAS 405060-95-9 Salubrinal

Salubrinal
(CAS: 405060-95-9)

Salubrinal is a selective inhibitor of eIF2α dephosphorylation and inhibits ER stress-mediated apoptosis with EC50 of ~15 μM.

UK-371804
(CAS: 256477-09-5)

UK-371804 is a novel and selective inhibitors of urokinase plasminogen activator (uPA). UK-371804 exhibits excellent enzyme potency (Ki 10 nM) and selectivity p...

Faropenem potassium
(CAS: 106559-89-1)

Faropenem potassium is an orally active beta-lactam antibiotic. It is a prodrug of Faropenem and belongs to the penem group. It is resistant to some forms of ex...

CAS 891025-25-5 BAMB-4

BAMB-4
(CAS: 891025-25-5)

BAMB-4 is a new membrane-permeable inhibitor against inositol-1,4,5-trisphosphate-3-kinase A((ITPKA). It exhibits the lowest inhibition frequency among the InsP...

Chemical Structure

CAS 66852-54-8 Halobetasol propionate

Quick Inquiry

Verification code

Featured Items